Citation: B. Ringe et al., Treatment of hepatic metastases from gastroenteropancreatic neuroendocrinetumors: Role of liver transplantation, WORLD J SUR, 25(6), 2001, pp. 697-699
Authors:
Ringe, B
Braun, F
Schutz, E
Fuzesi, L
Lorf, T
Canelo, R
Oellerich, M
Ramadori, G
Citation: B. Ringe et al., A novel management strategy of steroid-free immunosuppression after liver transplantation: Efficacy and safety of tacrolimus and mycophenolate mofetil, TRANSPLANT, 71(4), 2001, pp. 508-515
Authors:
Braun, F
Lorf, T
Schutz, E
Canelo, R
Hanack, U
Dopkens, K
Sattler, B
Grupp, C
Ringe, B
Citation: F. Braun et al., Primary tacrolimus immunosuppression in kidney recipients considered "higher immunological risk", TRANSPLAN P, 32(7), 2000, pp. 1688-1688
Authors:
Braun, F
Lorf, T
Schutz, E
Canelo, R
Hanack, U
Dopkens, K
Sattler, B
Grupp, C
Ringe, B
Citation: F. Braun et al., Primary tacrolimus immunosuppression in kidney recipients considered "higher immunologic risk", TRANSPLAN P, 32(7), 2000, pp. 2535-2535
Authors:
Canelo, R
Braun, F
Dopkens, K
Ramadori, G
Ringe, B
Citation: R. Canelo et al., Characterization and influence of risk factors on initial liver function after transplantation, TRANSPLAN P, 32(1), 2000, pp. 60-61
Authors:
Braun, F
Canelo, R
Lorf, T
Schutz, E
Grupp, C
Muller, GA
Ringe, B
Citation: F. Braun et al., Living-related versus living-unrelated kidney transplantation using tacrolimus initial immunosuppression, TRANSPLAN P, 32(1), 2000, pp. 115-116